Rockwell Medical (RMTI) Cash from Financing Activities (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Cash from Financing Activities came in at -$683000.0 in Q2 2026, down 5.08% on a YoY basis from -$719530.0 in Q2 2025, and up 15.99% quarter-over-quarter from -$813000.0 in Q1 2026.
Powered by 
Analysis
Rockwell Medical (RMTI) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has reported Cash from Financing Activities for 17 consecutive years, with -$683000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities fell 5.08% year-over-year to -$683000.0; the trailing twelve-month figure through Jun 2026 stood at $4.2 million (up 14.08% YoY), and the FY2025 full-year result was $4.3 million, down 42.13% from the prior year.
- Cash from Financing Activities grew to -$683000.0 in Q2 2026 per RMTI's latest filing, from -$813000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $26.8 million in Q2 2022 and bottomed at -$6.0 million in Q4 2022.
- Historically, Cash from Financing Activities has averaged $2.1 million across 5 years, with a median of -$640500.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities soared 447150.0% in 2022, then slumped 539.89% in 2025.
- Over 5 years, Cash from Financing Activities stood at -$6.0 million in 2022, then jumped by 87.6% to -$742000.0 in 2023, then soared by 476.28% to $2.8 million in 2024, then sank by 137.93% to -$1.1 million in 2025, then surged by 35.51% to -$683000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$683000.0, -$813000.0, and -$1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | -577.00 Mn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | -159.00 Mn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | -164.80 Mn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | -31.00 Mn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | -2.21 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | -11.16 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | -683,000.00 |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | -198,146.00 |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | 161,479.00 |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -683,000.00 |
| Mar 31, 2026 | -813,000.00 |
| Dec 31, 2025 | -1.06 Mn |
| Sep 30, 2025 | 6.74 Mn |
| Jun 30, 2025 | -650,000.00 |
| Mar 31, 2025 | -783,000.00 |
| Dec 31, 2024 | 2.79 Mn |
| Sep 30, 2024 | 2.31 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Mar 31, 2024 | 178,000.00 |
| Dec 31, 2023 | -742,000.00 |
| Sep 30, 2023 | 12.85 Mn |
| Jun 30, 2023 | -130,000.00 |
| Mar 31, 2023 | -631,000.00 |
| Dec 31, 2022 | -5.98 Mn |
| Sep 30, 2022 | -2.00 Mn |
| Jun 30, 2022 | 26.82 Mn |
| Mar 31, 2022 | -2.69 Mn |
| Dec 31, 2021 | -1.62 Mn |
| Sep 30, 2021 | -549,000.00 |